Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$879K Sell
20,815
-57,498
-73% -$2.69M ﹤0.01% 2066
2025
Q4
$3.77M Buy
78,313
+40,336
+106% +$1.84M ﹤0.01% 1149
2025
Q3
$1.68M Sell
37,977
-3,407
-8% -$158K ﹤0.01% 1546
2025
Q2
$2.07M Buy
41,384
+10,867
+36% +$612K ﹤0.01% 1315
2025
Q1
$2.05M Sell
30,517
-18,862
-38% -$1.37M ﹤0.01% 1239
2024
Q4
$3.9M Buy
49,379
+2,098
+4% +$181K 0.01% 889
2024
Q3
$4.06M Buy
47,281
+11,755
+33% +$878K 0.01% 863
2024
Q2
$2.44M Buy
35,526
+5,771
+19% +$381K ﹤0.01% 1014
2024
Q1
$1.84M Buy
29,755
+8,332
+39% +$445K ﹤0.01% 1154
2023
Q4
$1.05M Buy
21,423
+4,546
+27% +$212K ﹤0.01% 1394
2023
Q3
$742K Buy
+16,877
New +$726K ﹤0.01% 1513

Other funds holding SLVM

Mariner's SLVM Position: Q1 2026 in Review

Mariner reduced its Sylvamo (SLVM) stake by 73% in Q1 2026, selling an estimated $2.69M and leaving 20,815 shares worth $879K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

Mariner first reported a position in SLVM in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.06M in Q3 2024. 320 funds tracked by Wall St. Rank hold SLVM as of Q1 2026.

  • Mariner held 20,815 shares of Sylvamo worth $879K as of Q1 2026.
  • Mariner sold 57,498 Sylvamo shares in Q1 2026, an estimated $2.69M.
  • Sylvamo made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2066 holding.
  • Mariner first reported a position in Sylvamo in Q3 2023 and has held it in 11 quarters since.
  • Mariner's Sylvamo position peaked at $4.06M in Q3 2024.
  • 320 funds tracked by Wall St. Rank held Sylvamo as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.